Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma (Q33364240)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma |
scientific article |
Statements
1 reference
Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma (English)
1 reference
Barbara Pro
1 reference
Andre Goy
1 reference
Anas Younes
1 reference
Peter McLaughlin
1 reference
Jorge E Romaguera
1 reference
Frederick Hagemeister
1 reference
Nam H Dang
1 reference
Felipe Samaniego
1 reference
Michael Wang
1 reference
Kristine Broglio
1 reference
Barry Samuels
1 reference
Frederic Gilles
1 reference
Andreas H Sarris
1 reference
Susan Hart
1 reference
Elizabeth Trehu
1 reference
David Schenkein
1 reference
Alma M Rodriguez
1 reference
21 December 2004
1 reference
1 reference
Identifiers
1 reference